Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

sanjiv

Relay Therapeutics appoints Allergan CSO to CEO position

April 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Relay

Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel …
Appointment
shutterstock_292920209

Care Quality Commission targets website which gave prescriptions in 17 seconds

April 6, 2017 Medical Communications, Sales and Marketing Care Quality Commission, prescription

The Care Quality Commission (CQC), England’s health and social care service regulator, has identified four online prescription medicine vendors engaging …
News
joanne_estell

Joanne Estell joins Shield Therapeutics as CFO

April 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shield Therapeutics has announced that it has recruited Joanne Estell as its new CFO and board member; she will step …
Appointment
shire_image_4

NICE turns down Shire’s pancreatic cancer treatment

April 4, 2017 Manufacturing and Production, Sales and Marketing NICE, Pancreatic cancer, Shire

NICE has announced its intention not to recommend the NHS use of Shire’s Onivyde (pegylated liposomal irinotecan) for the treatment …
News
hero-plus

Mylan hit with fresh lawsuit over EpiPen pricing

April 4, 2017 Manufacturing and Production, Sales and Marketing Mylan, epipen, pricing

Just as it faces worldwide reports that over 80,000 of its EpiPens do not function properly and as the FDA …
News
teva_copy

Teva’s Huntington’s treatment becomes first FDA-approved deuterated drug

April 4, 2017 Manufacturing and Production, Sales and Marketing Austedo, FDA, Teva

Israel’s Teva Pharmaceuticals has announced that the FDA has given its approval for Austedo (deutetrabenazine) in the treatment of chorea …
News
shutterstock_254160583

Sanofi to pay $20m fine for overcharging US veterans

April 4, 2017 Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US

Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …
News
european_commission

Novartis combo expands into lung cancer with EU approval

April 4, 2017 Manufacturing and Production, Sales and Marketing NSCLC, Novartis, Tafinlar, mekinist

Novartis has announced that its Tafinlar (dabrafenib) and Mekinist (trametinib) drug combo has been approved by the European Commission (EC) …
News
robert_ring

Vencerx Therapeutics ring the changes appointing ex-Pfizer Director as CEO

April 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vencerx therapeutics

Vencerx Therapeutics, a biotech focused on developing treatments for neurodevelopmental disorders, has announced the appointment of Robert Ring as CEO. …
Appointment
rare_disease_day_logo

Behind Rare Disease Day 2017

April 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Rare Disease Day, rare disease

Rare Disease Day falls on the last day of February, meaning every four years it occurs on a leap year, …
Feature
blood-1813410_960_720

Finger-prick blood test could help with depression medication

April 3, 2017 Research and Development, Sales and Marketing

Researchers from the University of Texas Southwestern Medical Center have found that simple finger-prick blood test could reveal the most …
News
800px-university_of_pittsburgh_tablet2

Immune system influences immunotherapy effectiveness, research shows

April 3, 2017 Research and Development, Sales and Marketing immunotherapy, nivolumab, opdivo

Preliminary research conducted at the University of Pittsburgh Cancer Institute (UPCI) has discovered a link between levels of certain immune …
News

Pfizer secures expanded approval for Ibrance

April 3, 2017 Sales and Marketing Pfizer, ibrance

Pfizer has announced that FDA has approved its supplemental New Drug Application (sNDA) for Ibrance, meaning that the drug is …
News
1280px-epi-pen_1

FDA issues US-wide recall of Mylan’s EpiPen

April 3, 2017 Medical Communications, Sales and Marketing FDA, Mylan, epipen

After recent reports of around 80,000 defective EpiPen’s across Australia, New Zealand, Japan, Norway, Denmark, Finland and Ireland, the FDA …
News
astellas_tokyo_copy

Astellas lines up Ogeda for acquisition in $853 million deal

April 3, 2017 Sales and Marketing Astellas, Ogeda SA, menopause

Astellas, based in Tokyo, has announced that it has agreed a deal to acquire Belgium-based Ogeda SA. The deal will …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026